Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a citation regarding improved survival with ipilimumab in patients with metastatic melanoma, which may affect the credibility of the information presented.
    Difference
    0.8%
    Check dated 2025-05-08T14:16:40.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:33:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T01:43:36.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study descriptions for a Phase I/II trial involving blinatumomab and pembrolizumab for adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Additionally, the page now includes new collaborators and a revision update.
    Difference
    36%
    Check dated 2025-04-16T20:41:55.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T16:04:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in focus from Acute Graft Versus Host Disease to Acute Lymphoblastic Leukemia, along with an update in the version number from v2.14.2 to v2.14.3.
    Difference
    0.4%
    Check dated 2025-04-02T00:37:53.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.